DG Capital Management, LLC 13F holdings, Q2 2026
Holdings as of June 30, 2026 · filings on SEC EDGAR · this is the latest filing on record
DG Capital Management, LLC disclosed 20 US equity positions worth $288.7m in its Q2 2026 13F filing. The largest position was MCY at 17.8% of the reported book, followed by TLN and XE. Against the Q1 2026 filing, it opened 8 new positions, added to 4 and reduced 6 among the top 20 holdings.
What did DG Capital Management, LLC own in Q2 2026? Top 20 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q1 2026 |
|---|---|---|---|---|---|---|---|
| 1 | MCY MERCURY GENL CORP NEW | Financial Services | 17.8% | $51.5m | 482,663 | -19% | reduced |
| 2 | TLN TALEN ENERGY CORP | Utilities | 13.6% | $39.4m | 102,507 | -9% | reduced |
| 3 | XE X-ENERGY INC | Industrials | 9.6% | $27.8m | 1,512,339 | – | new |
| 4 | CBZ CBIZ INC | Industrials | 7.3% | $21.2m | 660,000 | – | new |
| 5 | RIOT PLATFORMS INC | 6.6% | $19.1m | 9,500,000 | -17% | reduced | |
| 6 | GDDY GODADDY INC | Technology | 6.2% | $18.0m | 211,720 | 2% | added |
| 7 | ABVX ABIVAX SA | Healthcare | 5.6% | $16.3m | 122,267 | – | new |
| 8 | CAPR CAPRICOR THERAPEUTICS INC | Healthcare | 5.1% | $14.7m | 611,595 | 56% | added |
| 9 | MAGN MAGNERA CORP | 4.5% | $12.9m | 1,101,476 | -9% | reduced | |
| 10 | BSX BOSTON SCIENTIFIC CORP | Healthcare | 4.4% | $12.8m | 300,000 | – | new |
| 11 | GLNG GOLAR LNG LTD | Energy | 4.3% | $12.4m | 248,100 | 0% | held |
| 12 | BUR BURFORD CAPITAL LIMITED | Financial Services | 3.2% | $9.2m | 2,244,180 | 2295% | added |
| 13 | GLNG GOLAR LNG LTD | 3.0% | $8.5m | 7,500,000 | – | new | |
| 14 | OWL BLUE OWL CAPITAL INC | Financial Services | 2.9% | $8.4m | 962,954 | -5% | reduced |
| 15 | MSDL MORGAN STANLEY DIRECT LENDIN | 2.5% | $7.2m | 475,537 | -17% | reduced | |
| 16 | AZUL S A | 1.9% | $5.5m | 616,433 | – | new | |
| 17 | GEL GENESIS ENERGY L P | 0.7% | $1.9m | 135,140 | 42% | added | |
| 18 | EQ EQUILLIUM INC | 0.5% | $1.5m | 463,396 | – | new | |
| 19 | UTHR UNITED THERAPEUTICS CORP DEL | Healthcare | 0.1% | $302.3k | 558 | 0% | held |
| 20 | ZOOZ STRATEGY LTD | 0.0% | $103.4k | 18,666 | – | new |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.